Funder: National Institutes of Health
Due Dates: February 19, 2026 (estimated, forecasted)
Funding Amounts: $250,000–$500,000 per award; estimated total program funding $3,000,000; up to 4 awards
Summary: Supports transformative, innovative research projects with the potential for major impact on Down syndrome and its co-occurring conditions.
Key Information: No preliminary data required; clinical trials not allowed; forecasted opportunity.